跳至主要内容
临床试验/NCT05727007
NCT05727007已完成不适用

Evaluation of Computed Tomography and Magnetic Diffusion Resonance Imaging in the Preoperative Staging of Colon Cancer

Larissa University Hospital2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年1月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Diagnostic accuracy in T stage

研究概览

简要总结

The objective of this study is the evaluation of different imaging methods for the optimal preoperative staging of colon cancer patients. Imaging findings will be compared with the histopathologic results of the specimen following surgical resection.

详细描述

Over the last years a significant improvement in the treatment of patients with colon cancer has been reported. This has been attributed to the improvement of the staging techniques, as well as the optimization of the surgical management. However, the current five-year survival rates of colon cancer patients in European countries ranges from 32% to 64%. This variation could be due to treatment discrepancies and the lack of adherence to the international guidelines.

Surgical treatment of colon cancer includes the radical resection of the tumour (colectomy). Following resection, the specimen is histopathologically examined, the disease is staged and further treatment is determined. Neoadjuvant treatment (radiotherapy or/and chemotherapy) for colon cancer has not been yet approved, unlike rectal cancer, where neoadjuvant treatment is recommended for specific disease stages.

Preoperative staging of colon cancer aims to identify those patients with remote metastatic disease, who will, more likely, not benefit from upward surgery. Recent developments in colon cancer management, demanding more precise local disease staging, to identify those patients who will likely benefit from neoadjuvant chemotherapy, are still at a clinical trial stage.

Preoperative treatment depends on the disease stage, which is defined by the tumour's invasion in the colonic wall, the dissemination in nearby organs or lymph nodes, and the presence of distal metastases. The stage is first evaluated radiologically and then confirmed via histopathological examination of the specimen. Imaging is an already approved tool for the staging of colonic cancer, while in some studies the combination of different imaging methods has been reported to improve the initial evaluation.

Over the last years, evaluation of the circumferential resection margin (CRM) is also recommended in the preoperative staging of patients with colon cancer. This assessment is particularly important for tumours located at the cecum, right, or left colon, since these areas lack of mobile mesocolon and therefore it is possible to infiltrate the retroperitoneal resection margin.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

There will be no blindness at the level of the patient, the treating physicians (surgeon, oncologist, radiologist) and the researcher who will record the data

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed colonic adenocarcinoma
  • Patient 18 to 90 years old
  • Abscence of comorbidities that may affect treatment
  • Signed informed consent of the patient

排除标准

  • Inability to receive or contraindication for intravenous contrast
  • Renal impairment
  • Previous allergies to intravenous contrasts
  • Incompatible implants with magnetic resonance imaging
  • Claustrophobia
  • Active sepsis or systemic infection
  • Untreated physical and mental disability
  • Lack of compliance with the protocol process
  • Non-granting of signed informed consent

结局指标

主要结局

Diagnostic accuracy in T stage

时间窗: 1 month postoperatively

Evaluation of diagnostic accuracy in the T stage assessment. Diagnostic accuracy will be evaluated in terms of specificity (true negative rate)

次要结局

  • Diagnostic accuracy in the retroperitoneal resection margin(1 month postoperatively)
  • Diagnostic accuracy in N stage(1 month postoperatively)
  • Diagnostic accuracy in peritoneal or nearby organ infiltration(1 month postoperatively)

研究者

发起方
Larissa University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Effrosyni Bompou

Effrosyni Bompou Principal Investigator

Larissa University Hospital

研究点 (2)

Loading locations...

相似试验